Recursion Pharmaceuticals (RXRX) EPS (Basic) (2020 - 2026)
Recursion Pharmaceuticals' (RXRX) quarterly EPS (Basic) came in at -$0.22 in Q1 2026, up 55.84% YoY from -$0.14 in Q1 2025, and up 8.13% on a QoQ basis from -$0.24 in Q4 2025.
Recursion Pharmaceuticals (RXRX) EPS (Basic) (2020 - 2026) Analysis & Trends
Recursion Pharmaceuticals (RXRX) has 7 years of EPS (Basic) data on file, last reported at -$0.22 in Q1 2026.
- Quarterly EPS (Basic) rose 55.84% year-over-year to -$0.22 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.06 (up 25.89% YoY) and the FY2025 annual result came in at -$1.44, up 14.78% from the prior year.
- EPS (Basic) improved to -$0.22 in Q1 2026, from -$0.24 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of -$0.22 in Q1 2026 to a low of -$0.65 in Q4 2024.
- A 5-year average of -$0.39 and a median of -$0.38 in 2022 frame the typical range for EPS (Basic).
- Annual changes were most pronounced in 2022 — EPS (Basic) soared 75.42% — and 2024, when it plunged 45.83%.
- Tracing RXRX's EPS (Basic) over 5 years: stood at -$0.39 in 2022, then slipped by 15.41% to -$0.45 in 2023, then plunged by 45.83% to -$0.65 in 2024, then soared by 62.96% to -$0.24 in 2025, then advanced by 8.13% to -$0.22 in 2026.
- The last three EPS (Basic) figures came in at -$0.22 (Q1 2026), -$0.24 (Q4 2025), and -$0.36 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 7.59 |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -3.06 |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 0.16 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 0.00 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.18 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.23 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -0.06 |
| 10 | Recursion Pharmaceuticals | 1.69 Bn | 1.14 Bn | -3.82 Mn | -0.25 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.25 |
| Mar 31, 2026 | -0.22 |
| Dec 31, 2025 | -0.24 |
| Sep 30, 2025 | -0.36 |
| Jun 30, 2025 | -0.41 |
| Mar 31, 2025 | -0.50 |
| Dec 31, 2024 | -0.65 |
| Sep 30, 2024 | -0.34 |
| Jun 30, 2024 | -0.40 |
| Mar 31, 2024 | -0.39 |
| Dec 31, 2023 | -0.45 |
| Sep 30, 2023 | -0.43 |
| Jun 30, 2023 | -0.38 |
| Mar 31, 2023 | -0.34 |
| Dec 31, 2022 | -0.39 |
| Sep 30, 2022 | -0.36 |
| Jun 30, 2022 | -0.38 |
| Mar 31, 2022 | -0.33 |
| Dec 31, 2021 | -0.52 |
| Sep 30, 2021 | -0.28 |